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United States  
Environmental Protection Agency 
Office of Prevention, Pesticides and Toxic Substances 
(7505P) 
_______________________________________________________ 
Pesticide 
Fact Sheet 
 
Name of Chemical: Mammalian Gonadotropin 
Releasing Hormone (GnRH) 
Reason for Issuance:          New Chemical 
                                             Nonfood Use 
Date Issued:                        September 2009 
_______________________________________________________ 
 
 
1. Description of Chemical 
 
Peptide Chain: pyroGlu1 -His2-Trp3- Ser4 -Tyr5- Gly6 -Leu7-Arg8-
Pro9- G ly10NH2 [GnRH] 
 
Common Name: Mammalian Gonadotropin Releasing Hormone (GnRH) 
 
EPA PC Code:        116800 
 
Chemical Abstracts  
Service (CAS) Number:  9034-40-6 
 
Chemical Class:   Sterilant/Hormone 
 
Registration Status:   New Chemical, nonfood use 
 
Pesticide Type:   Mammalian Contraceptive  
 
U.S. Producer: U.S. Department of Agriculture, APHIS, Pocatello 
Supply Depot 
 238 East Dillon Street 
 Pocatello, ID 83201 
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2. Use Pattern and Formulations 
 
Mode of Action The active ingredient, Mammalian Gonadotropin Releasing                  
Hormone (GnRH) is conjugated into a large protein that 
initiates an immune response in the animal with its own GnRH 
resulting in contraceptive effects for a minimum of one year.  
 
Application Sites   GonaCon will be used to control wild white-tailed deer 
Odocoileus virginianus) populations in areas where they have 
become a nuisance (e.g, urban and suburban settings).   
    
Methods of  
Application     The vaccine will be administered to restrained female deer 
using preloaded syringes with an 18 or 19 gauge stainless steel 
hypodermic needle intramuscularly into a large muscle mass by 
hand injection only.   
      
       GonaCon is classified as a Restricted Use Pesticide.  Use is 
restricted to USDA APHIS Wildlife Services or state wildlife 
management personnel or persons working under their 
authority.   
 
Application Rate:   Female deer are injected with a single injection containing 1.0 
ml of GonaCon at least two to three months prior to the onset 
of rut for full contraceptive effect. If multi year contraceptive 
effects are desired, a second vaccination may be given 30 to 60 
days after the first injection or during the following year.  
        
       Two formulations (basic and alternate) are proposed for 
registration. 
3. Science Findings 
 
Available data supporting the use and registration of Mammalian Gonadotropin 
Releasing Hormone including product chemistry, toxicology, efficacy, and ecological 
effects and environmental fate are summarized below.   
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Table 1.  Product Chemistry Summary 
Peptide structure 
 
 
Common name Mammalian Gonadotropin Releasing Hormone (GnRH) 
CAS Reg. No. 9034-40-6 
Color white 
Physical State 
Active: solid:  powder 
EU:  liquid: somewhat creamy in appearance 
Melting Point N/A Waiver request 
Boiling Point Waiver request: Solid at room temperature. 
Odor 
Active:  odorless 
EU:  odorless  
Stability to Normal and 
Elevated Temperatures, 
Metal, and Metal Ions 
N/A Waiver request 
Oxidation/Reduction 
Action N/A Waiver request 
pH 
Active:  NA 
EU: pH = 6.49 
Flammability N/A Waiver request 
Explodability N/A Waiver request 
Vapor pressure N/A Waiver request 
Water Solubility N/A Waiver request 
Storage stability N/A product’s shelf life will be < 6 months so not necessary 
Corrosion Characteristics N/A product’s shelf life will be < 6 months so not necessary 
 
TOXICOLOGY SUMMARY 
 
The Registrant submitted the studies listed in Tables 2, which include a number of toxicity 
studies. The Registrant submitted waiver requests which were granted for acute inhalation 
and dermal sensitization.  
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Acute Toxicity Data GnRH 
 
Table 2.  Acute Toxicity 
 
Guideline 
No. 
 
 
Study Type 
 
Results 
Toxicity 
Category* 
OPPTS  
870.1100 
Acute Oral  
Rat 
All test animals survived 1 mL 
exposure. 
 
 
IV 
OPPTS  
870.1200 
Acute Dermal   
Rat 
All test animals survived 1 mL 
exposure. 
 
 
IV 
OPPTS  
870.1300 
Acute Inhalation  
Rat 
WAIVED  
IV 
OPPTS  
870.2400 
Primary Eye Irritation  
Rabbit 
No corneal opacity or iritis was 
observed.  1-hour post-
instillation: 3/3 treated eyes 
exhibited conjunctival redness 
(score 1-2) and discharge (score 
1).  No “positive” grade 
irritation was noted at the 24-
hour observation.  Treated eyes 
were free of all eye irritation by 
72-hours.   
 
IV 
OPPTS  
870.2500 
Primary Skin Irritation  
Rabbit 
No edema was observed at any 
treated site.  Very slight 
erythema (score 1) was noted at 
all 3/3 test sites within 1-hour 
post-pad removal.  Irritation 
severity decreased thereafter.  
No irritation was noted at the 
72-hour observation.  The PDII 
was 0.5.  
 
IV 
OPPTS  
870.2600 
Dermal sensitization  
 
WAIVED   
-- 
 
• Toxicity Category IV = No precautions required 
 
Chronic toxicity data requirements were waived.  There is no human exposure from use 
of GonaCon, therefore no toxicity endpoints were selected because of the very limited 
potential worker and dietary exposure.   
 
 
ECOLOGICAL EFFECTS 
 
Waivers were submitted to fulfill required ecological effects and environmental fate 
guideline studies for the registration of GonaCon because of the limited potential for 
environmental releases.  Since the product is labeled only for injection to deer by hand 
and the substance is expected to be rapidly metabolized in treated animals, the limited 
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potential risks to non-target organisms resulting from the proposed registration of 
GonaCon are not expected to exceed the Agency’s concern levels.  
 
The proposed registration of GonaCon is expected to have no effect on endangered or 
threatened species 
 
EFFICACY 
 
GonaCon is intended to render a vaccinated female white-tailed deer infertile for a 
minimum of one year following vaccination. GonaCon is not expected to affect existing 
pregnancies but should cause infertility of the vaccinated animal in subsequent years. If 
multi-year contraceptive effects are desired, a second vaccination may be given 30-60 
days after the first injection or during the following year. There is a chance that some 
vaccinated females will become permanently sterile.  
 
Product performance studies were conducted by APHIS’s National Wildlife Research 
Center (NWRC) both in the field over a two year period and in a laboratory over multiple 
years to compare two different formulations.  
 
The field test, initiated in 2004 used two sites consisting of fenced federal land near 
Silver Spring, MD. Female deer in the vaccinated group were dosed with the labeled rate 
of the vaccine during July and August 2004. All deer were marked with ear tags and 
radio telemetry collars equipped with mortality sensors. Reproductive status was assessed 
in the summers of 2005 and 2006 with visual inspection of the udders for signs of 
lactation.    
 
Results showed 88% efficacy in the summer after vaccination with lactation evident in 3 
of the 26 does vaccinated (12%). Of the control group, reproductive status was able to be 
determined in 13 of the 15 deer and lactation was evident in 11 of those 13 doe (85%). 
 
In the second summer after vaccination lactation was evident in 10 of the remaining 19 
vaccinated deer (53%) equating to an efficacy rate of 47%. In the control group, 10 of the 
10 remaining deer (100%) had reproductive success. 
 
The lab study results showed the alternate formulation to be more effective than the basic 
formulation. The alternate formulation had a 100% success rate (5/5 does remained 
contracepted for two years) compared to the basic formulation with a 60% success rate 
after two years (3/5 does contracepted). Due to economic and supply reasons however, it 
is necessary for the product to carry both formulations.   
 
4. Summary of Regulatory Position and Rationale 
 
Available data provide adequate information to support the conditional registration of 
GnRH as a tool for management of nuisance white-tailed deer.  
 
White-tailed deer have been classified by EPA as a public health pest because they are a 
host for blacklegged ticks (Ixodes scapularis), more commonly known as deer ticks, 
which are a carrier of Lyme disease.   
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In many urban and suburban areas white-tailed deer populations have become over 
abundant and are considered a year-round nuisance causing many human-wildlife 
conflicts such as destruction on gardens, landscapes and golf courses as well as a cause of 
numerous vehicle accidents. According to a 2006 study, the National Highway Traffic 
Safety Administration reported that there are about 1.5 million car accidents with deer 
resulting in over $1 billion of damage and 150 human fatalities annually. 
 
GonaCon is intended to be used in combination with other management techniques since 
it cannot alone reduce already over abundant populations.  
 
5. Labeling Restrictions 
 
To mitigate any risks, the following requirements have been imposed:  
 
• Restricted -Use Pesticide classification due to non-target injection hazard.   
 
• Application is restricted to USDA APHIS Wildlife Services or state wildlife 
management agency personnel or persons working under their authority only. 
 
• Administration of vaccine is only by hand injection to mitigate any non-target or 
environmental risks that occur with administration with darts. 
 
• Use restricted to only one species: white-tailed deer (Odocoileus virginianus). 
 
• PPE requirements include: long sleeved shirt and long pants, gloves and shoes 
plus socks to mitigate occupational exposure. 
 
• Children are not allowed in areas where product is used 
 
• A warning that pregnant women should not be involved in handling or injecting 
GonaCon and that all women should be aware that accidental self-injection may 
cause infertility. 
 
6. Conditional Data Requirements 
 
Because of the unique chemical nature of GnRH additional preliminary analysis and 
certified limits data are necessary.  The registrant must submit this data to the Agency 
upon completion. 
 
Conditional data required for GonaCon consists of: 
 
• Guideline 830.1700 Validating the method of analysis of the formulation and 
additional preliminary analysis 
• Guideline 830.1750 Certified Limits 
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Contact Person at USEPA 
 
Mailing address: 
 
Autumn Metzger 
Biologist, Insecticide-Rodenticide Branch 
Environmental Protection Agency 
Office of Pesticide Programs 
Registration Division (7505P) 
Insecticide Branch 
1200 Pennsylvania Avenue NW 
Washington, D.C. 20460 
 
Office location and telephone number:  
 
Room S-7224, One Potomac Yard 
2777 S. Crystal Drive 
Arlington, VA 22202 
703-305-5314 
 
 
DISCLAIMER: The information in this Pesticide Fact Sheet is for information only 
and is not to be used to satisfy data requirements for pesticide registration. The 
information is believed to be accurate as of the date on the document.  
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APPENDIX I 
GLOSSARY OF TERMS AND ABBREVIATIONS 
ADNT Acute delayed neurotoxicity 
a.i. Active Ingredient 
aPAD Acute Population Adjusted Dose 
ARI Aggregate Risk Index 
BCF Bioconcentration Factor 
CAS Chemical Abstracts Service 
ChE Cholinesterase 
ChEI Cholinesterase inhibition 
cPAD Chronic Population Adjusted Dose 
%CT Percent crop treated 
DAT Days after treatment 
DEEM-FCID Dietary Exposure Evaluation Model - Food Consumption Intake Database  
DNA Deoxyribonucleic acid  
DNT Developmental neurotoxicity  
DIT Developmental immunotoxicity  
DWLOC   Drinking Water Level of Comparison.  
EC Emulsifiable Concentrate Formulation  
EEC  Estimated Environmental Concentration. The estimated pesticide 
 concentration in an environment, such as a terrestrial ecosystem.  
EPA U.S. Environmental Protection Agency  
FQPA Food Quality Protection Act  
GLC Gas Liquid Chromatography  
GLN Guideline Number  
LC50    Median Lethal Concentration. A statistically derived concentration of a 
substance that can be expected to cause death in 50% of test animals. It is 
usually expressed as the weight of substance per weight or volume of 
water, air or feed, e.g., mg/l, mg/kg or ppm.  
LD50   Median Lethal Dose. A statistically derived single dose that can be 
expected to cause death in 50% of the test animals when administered by 
the route indicated (oral, dermal, inhalation). It is expressed as a weight of 
substance per unit weight of animal, e.g., mg/kg.  
LOAEL Lowest Observed Adverse Effect Level  
LOAEC Lowest Observed Adverse Effect Concentration  
LOC Level of Concern  
LOD Limit of Detection  
LOQ Limit of Quantitation  
mg/kg/day Milligram Per Kilogram Per Day  
mg/L Milligrams Per Liter  
MOE Margin of Exposure 
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MRID Master Record Identification (number), EPA's system of recording and 
tracking studies submitted  
MTD Maximum tolerated dose  
NA Not Applicable  
NOEC No Observable Effect Concentration  
NOEL No Observed Effect Level  
NOAEL No Observed Adverse Effect Level  
NOAEC No Observed Adverse Effect Concentration  
NPDES National Pollutant Discharge Elimination System  
OP Organophosphate  
OPP EPA Office of Pesticide Programs  
OPPTS EPA Office of Prevention, Pesticides and Toxic Substances  
PAD Population Adjusted Dose  
PAG Pesticide Assessment Guideline  
PAM Pesticide Analytical Method  
PHED Pesticide Handler's Exposure Data  
PHI Preharvest Interval  
ppb Parts Per Billion  
PPE Personal Protective Equipment  
ppm Parts Per Million  
PRZM/EXAMS  Tier II Surface Water Computer Model  
RAC   Raw Agriculture Commodity  
RBC Red Blood Cell  
RED Reregistration Eligibility Decision  
REI Restricted Entry Interval  
RfD Reference Dose  
SCI-GROW Tier I Ground Water Computer Model  
SF Safety Factor  
TGAI Technical Grade Active Ingredient  
UF Uncertainty Factor  
µg micrograms  
µg/L Micrograms Per Liter  
µL/g Microliter per gram  
USDA United States Department of Agriculture  
WPS Worker Protection Standard 
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APPENDIX II 
 
Citations Considered Part of the Data Base Supporting the Registration of 
GonaCon. 
 
MRID Citation Receipt Date 
47649600 
United States Department of Agriculture's Animal and Plant Health 
Inspection Service (USDA APHIS) (2009) Submission of Product 
Chemistry, Toxicity, Efficacy and Residue Data in Support of the 
Application for Registration of GonaCon Immunocontraceptive Vaccine. 
Transmittal of 36 Studies. 
22-Jan-
2009 
47649601 
O'Hare, J.; Eisemann, J. (2008) Description of Materials Used to Produce: 
"GoneCon Immunocontraceptive Vaccine". Project Number: P4417. 
Unpublished study prepared by US Dept. of Agriculture, APHIS, WS: 
National Wildlife Research Center. 168 p. 
22-Jan-
2009 
47649602 
O'Hare, J.; Eisemann, J. (2008) Description of Formulation Process Used 
to Manufacture: "GonaCon Immunocontraceptive Vaccine". Project 
Number: M8546, BT016/02. Unpublished study prepared by US Dept. of 
Agriculture, APHIS, WS: National Wildlife Research Center. 99 p. 
22-Jan-
2009 
47649603 
O'Hare, J.; Pilon, J.; Eisemann, J. (2008) Discussion of the Formation of 
Impurities "GonaCon Immunocontraceptive Vaccine". Unpublished study 
prepared by US Dept. of Agriculture, APHIS, WS: National Wildlive 
Research Center. 56 p. 
22-Jan-
2009 
47649604 
O'Hare, J.; Eisemann, J.; Pilon, J. (2008) Preliminary Analysis and 
Certified Limits "GonaCon Immunocontraceptive Vaccine": Final Report. 
Unpublished study prepared by US Dept. of Agriculture, APHIS, WS: 
National Wildlife Research Center. 9 p. 
22-Jan-
2009 
47649605 
O'Hare, J.; Eisemann, J. (2008) Enforcement Analytical Method: 
"GonaCon Immunocontraceptive Vaccine". Unpublished study prepared 
by US Dept. of Agriculture, APHIS, WS: National Wildlife Research 
Center. 40 p. 
22-Jan-
2009 
47649606 
O'Hare, J.; Eisemann, J. (2007) Product Chemistry: Color, Physical State, 
Odor, and pH - USDA APHIS GonaCon Immunocontraceptive Vaccine 
(EPA Reg. No. 56228-xx): Final Report. Project Number: QA/1421. 
Unpublished study prepared by US Dept. of Agriculture, APHIS, WS: 
National Wildlife Research Center. 31 p. 
22-Jan-
2009 
47649607 
Warren, J.; Stephens, S. (2008) Stability to Normal and Elevated 
Temperatures, Metal, and Metal Ions: (Gonadotropin Releasing 
Hormone). Unpublished study prepared by US Dept. of Agriculture, 
APHIS, WS. 8 p. 
22-Jan-
2009 
47649608 
Warren, J.; Stephens, S. (2008) Oxidation/Reduction Chemical 
Incompatibility: (GonaCon Immunocontraceptive Vaccine). Unpublished 
study prepared by US Dept. of Agriculture, APHIS, WS. 8 p. 
22-Jan-
2009 
47649609 
Warren, J.; Stephens, S. (2008) Flammability: (GonaCon 
Immunocontraceptive Vaccine). Unpublished study prepared by USDA 
APHIS. 8 p. 
22-Jan-
2009 
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47649610 
Warren, J.; Stephens, S. (2008) Explodability: (GonaCon 
Immunocontraceptive Vaccine). Unpublished study prepared by USDA 
APHIS. 4 p. 
22-Jan-
2009 
47649611 
Warren, J.; Stephens, S. (2008) Miscibility: (GonaCon 
Immunocontraceptive Vaccine). Unpublished study prepared by USDA 
APHIS. 8 p. 
22-Jan-
2009 
47649612 
Warren, J.; Stephens, S. (2008) Corrosion Characteristics: (GonaCon 
Immunocontraceptive Vaccine). Unpublished study prepared by USDA 
APHIS. 8 p. 
22-Jan-
2009 
47649613 
Warren, J.; Stephens, S. (2008) Dielectric Breakdown Voltage: (GonaCon 
Immunocontraceptive Vaccine). Unpublished study prepared by USDA 
APHIS. 8 p. 
22-Jan-
2009 
47649614 Warren, J.; Stephens, S. (2008) UV/Visible Absorption: (GonaCon Immunocontraceptive). Unpublished study prepared by USDA APHIS. 8 p. 
22-Jan-
2009 
47649615 
Warren, J.; Stephens, S. (2008) Viscosity: (GonaCon 
Immunocontraceptive Vaccine). Unpublished study prepared by USDA 
APHIS. 8 p. 
22-Jan-
2009 
47649616 
Warren, J.; Stephens, S. (2008) Melting Point: (GonaCon 
Immunocontraceptive Vaccine). Unpublished study prepared by USDA 
APHIS. 8 p. 
22-Jan-
2009 
47649617 
Warren, J.; Stephens, S. (2008) Boiling Point: (GonoCon 
Immunocontraceptive Vaccine). Unpublished study prepared by USDA 
APHIS. 4 p. 
22-Jan-
2009 
47649618 
Warren, J.; Stephens, S. (2008) Density/Relative Density/Bulk Density: 
(GonaCon Immunocontraceptive Vaccine). Unpublished study prepared 
by USDA APHIS. 4 p. 
22-Jan-
2009 
47649619 
Warren, J.; Stephens, S. (2008) Dissociation Constant in Water: 
(GonaCon Immunocontraceptive Vaccine). Unpublished study prepared 
by USDA APHIS. 8 p. 
22-Jan-
2009 
47649620 
Warren, J.; Stephens, S. (2008) Octanol/Water Partition Coefficient: 
(GonaCon Immunocontraceptive Vaccine). Unpublished study prepared 
by USDA APHIS. 8 p. 
22-Jan-
2009 
47649621 
Warren, J.; Stephens, S. (2008) Water Solubility: (GonaCon 
Immunocontraceptive Vaccine). Unpublished study prepared by USDA 
APHIS. 8 p. 
22-Jan-
2009 
47649622 
Warren, J.; Stephens, S. (2008) Vapour Pressure: (GonaCon 
Immunocontraceptive Vaccine). Unpublished study prepared by USDA 
APHIS. 8 p. 
22-Jan-
2009 
47649623 
Eisemann, J.; O'Hare, J. (2008) Chemical Identity: "GonaCon 
Immunocontraceptive Vaccine". Unpublished study prepared by US Dept. 
of Agriculture, APHIS, WS: Natiional Wildlife Research Center. 27 p. 
22-Jan-
2009 
47649624 
Eisemann, J.; O'Hare, J. (2008) Direction for Use: GonaCon 
Immunocontraceptive Vaccine. Unpublished study prepared by US Dept. 
of Agriculture, APHIS, WS: National Research Center. 12 p. 
22-Jan-
2009 
47649625 Lowe, C. (2008) GonaCon Immunocontraceptive Vaccine: Acute Oral 22-Jan-
 11
Toxicity - Limit Dose Procedure in Rats. Project Number: P320/USDA, 
23211. Unpublished study prepared by Product Safety Laboratories. 28 p. 
2009 
47649626 
Lowe, C. (2008) GonaCon Immunocontraceptive Vaccine: Acute Dermal 
Toxicity - Limit Dose Procedure in Rats. Project Number: 23212, 
P322/USDA. Unpublished study prepared by Product Safety Laboratories. 
28 p. 
22-Jan-
2009 
47649627 
O'Hare, J.; Eisemann, J.; Stephens, S. (2008) Acute Inhalation Toxicity: 
(GonaCon Immunocontraceptive Vaccine). Unpublished study prepared 
by USDA APHIS. 4 p. 
22-Jan-
2009 
47649628 
Lowe, C. (2007) GonaCon Immunocontraceptive Vaccine: Primary Eye 
Irritation Study in Rabbits. Project Number: P324, 22806. Unpublished 
study prepared by Product Safety Laboratories. 29 p. 
22-Jan-
2009 
47649629 
Lowe, C. (2008) GonaCon Immunocontraceptive Vaccine: Primary Skin 
Irritation Study in Rabbits. Project Number: P326, 22807. Unpublished 
study prepared by Product Safety Laboratories. 27 p. 
22-Jan-
2009 
47649630 
O'Hare, J.; Eisemann, J.; Stephens, S. (2008) Dermal Sensitization: 
(GonaCon Immunocontraceptive Vaccine). Unpublished study prepared 
by USDA APHIS. 4 p. 
22-Jan-
2009 
47649631 
O'Hare, J.; Eisemann, J.; Stephens, S. (2008) Chronic Dietary Toxicity: 
(GonaCon Immunocontraceptive Vaccine). Unpublished study prepared 
by USDA APHIS. 4 p. 
22-Jan-
2009 
47649632 
O'Hare, J.; Eisemann, J.; Stephens, S. (2008) Gene Mutation: (GonaCon 
Immunocontraceptive Vaccine): (Human). Unpublished study prepared by 
USDA APHIS. 4 p. 
22-Jan-
2009 
47649633 
O'Hare, J.; Eisemann, J.; Stephens, S. (2008) Stuctural Chromosomal 
Aberration: (GonaCon Immunocontraceptive Vaccine): (Human). 
Unpublished study prepared by USDA APHIS. 4 p. 
22-Jan-
2009 
47649634 
O'Hare, J.; Eisemann, J.; Stephens, S. (2008) Other Genotoxic Effects: 
(GonaCon Immunocontraceptive Vaccine): (Human). Unpublished study 
prepared by USDA APHIS. 4 p. 
22-Jan-
2009 
47649635 
O'Hare, J.; Eisemann, J.; Stephens, S. (2008) Acute Delayed 
Neurotoxicity: (GonaCon Immunocontraceptive Vaccine): (Hen). 
Unpublished study prepared by USDA APHIS. 4 p. 
22-Jan-
2009 
47649636 
Gionfriddo, J.; Eisemann, J.; O'Hare, J. (2008) Product Performance: 
Field Test of a Single-Injection of GonaCon Immunocontraceptive Vaccine 
In Female White-Tailed Deer. Project Number: QA/1112. Unpublished 
study prepared by US Dept. of Agriculture, APHIS, WS: National Wildlife 
Research Center. 31 p. 
22-Jan-
2009 
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